Thu, Dec 25, 2014, 11:37 PM EST - U.S. Markets closed for Christmas

Recent

% | $
Quotes you view appear here for quick access.

Amarin Corporation plc Message Board

interestedmd 2 posts  |  Last Activity: May 10, 2013 10:12 AM Member since: May 10, 2013
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • It is important to note several very important facts:
    • For Vascepa, the MARINE indication is for pts with TG 500 mg/dL. If the ANCHOR indication were to be approved, it would be for pts with TG levels 200 and

  • interestedmd by interestedmd May 10, 2013 10:10 AM Flag

    1. The trial administered n-3 fatty acids at a dose of 1 gram /day with a study product that contained approximately 50% EPA and 50% DHA. This is similar to the proportional composition of Lovaza. This means that on a daily basis, the patients in the active treatment arm of the study received 0.5 grams of EPA per day. Of note, the placebo group was treated with olive oil.
    2. The following were the reported lipid data for the n-3 fatty acid and placebo arms of the trial as well as the percent of patients in each group who were treated with statin therapy.
    Baseline (Mean Values)
    n-3 Fatty Acid Placebo
    TG 150 mg/dL 150 mg/dL
    LDL-C 131.8 mg/dL 132.5 mg/dL
    % on Statin 40.8% 41.4%
    Change from Baseline
    n-3 Fatty Acid Placebo
    TG -28 mg/dL -28 mg/dL
    LDL-C -21.9 mg/dL -21.9 mg/dL
    % on Statin 61.8% 62.1%
    It is important to note several very important facts:
    • For Vascepa, the MARINE indication is for pts with TG 500 mg/dL. If the ANCHOR indication were to be approved, it would be for pts with TG levels 200 and

AMRN
0.9916-0.0021(-0.21%)Dec 24 1:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
KeyCorp.
NYSEWed, Dec 24, 2014 1:01 PM EST